Cargando…
Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: “MTD” or “ALARA”?
Locally advanced non-small cell lung cancer (LA-NSCLC) is typically treated with thoracic radiotherapy, often in combination with cytotoxic chemotherapy. Despite tremendous advances in the evaluation, treatment techniques, and supportive care measures provided to LA-NSCLC patients, local disease pro...
Autor principal: | Ohri, Nitin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613081/ https://www.ncbi.nlm.nih.gov/pubmed/28983464 http://dx.doi.org/10.3389/fonc.2017.00205 |
Ejemplares similares
-
Best practices for ALARA
por: ROESLER, Stefan
Publicado: (2014) -
Comparison of dose–volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer
por: Ohno, Toshiki, et al.
Publicado: (2015) -
ALARA in Pediatric Electrophysiology Laboratory
por: Singh, Harinder R.
Publicado: (2022) -
Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer
por: Abe, Takanori, et al.
Publicado: (2021) -
Practice of ALARA in the pediatric interventional suite
por: Connolly, Bairbre, et al.
Publicado: (2006)